---
title: "Tirofiban - Acute coronary syndrome"
sidebar: mydoc_sidebar
permalink: tirofibanacutecoronarysyndrome.html
toc: false 
---

{% include image.html file="tirofibanacutecoronarysyndrome.png" alt="tirofibanacutecoronarysyndrome" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| DB:DB00775 | Tirofiban | Drug |
| PR:000028445 | platelet glycoprotein (GP) IIb/IIIa receptor | MacromolecularComplex |
| InterPro:IPR030672 | Adenylate cyclase | GeneFamily |
| MESH:D000242 | cyclic AMP | ChemicalSubstance |
| GO:0070527 | platelet aggregation | BiologicalProcess |
| MESH:D054058 | Acute coronary syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Tirofiban | DECREASES ACTIVITY OF | Platelet Glycoprotein (Gp) Iib/Iiia Receptor |
| Platelet Glycoprotein (Gp) Iib/Iiia Receptor | NEGATIVELY REGULATES | Adenylate Cyclase |
| Adenylate Cyclase | DECREASES ABUNDANCE OF | Cyclic Amp |
| Cyclic Amp | PREVENTS | Platelet Aggregation |
| Platelet Aggregation | CORRELATED WITH | Acute Coronary Syndrome |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00775#mechanism-of-action](https://go.drugbank.com/drugs/DB00775#mechanism-of-action){:target="_blank"}